✦ LIBER ✦

Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression

✍ Scribed by Maffezzini, Massimo; Campodonico, Fabio; Canepa, Giorgio; Manuputty, Egi Edward; Tamagno, Stefania; Puntoni, Matteo

Book ID: 121535626
Publisher: Springer
Year: 2014
Tongue: English
Weight: 260 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2423-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1771 TREATMENT WITH INTRACUTANEOUS AND I

1771 TREATMENT WITH INTRACUTANEOUS AND INTRAVESICAL KEYHOLE LIMPET HEMOCYANIN IS INFERIOR TO INTRAVESICAL MITOMYCIN-C FOR PREVENTION OF RECURRENCES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE III TRIAL

✍ Lammers, Rianne J.M.; Witjes, Wim P.J.; Janzing-Pastors, Maria H.C.; Caris, Chri 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 121 KB

1051 Intracutaneous and intravesical imm

1051 Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin versus intravesical mitomycin-C for prevention of recurrences in patients with non-muscle-invasive bladder cancer: Results from a prospective randomized phase III trial

✍ Lammers, R.J.M.; Witjes, W.P.J.; Janzing-Pastors, M.H.C.; Caris, C.T.M.; Witjes, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 130 KB

S113 Comparison of second TURB outcomes

S113 Comparison of second TURB outcomes in patients with non muscle invasive bladder cancer in groups with low, intermediate and high risk for recurrence according by EORTC scoring system

✍ Shahrokh, H.; Shadpour, P.; Khaleghi, F. Mehr; Abol, M. Hasani; Narimani, N.; Mo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 79 KB